Anemia as a risk factor and therapeutic target in heart failure
- 27 August 2004
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 44 (5) , 959-966
- https://doi.org/10.1016/j.jacc.2004.05.070
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Effect of anemia on exercise tolerance in chronic heart failure in menThe American Journal of Cardiology, 2003
- The prevalence of anemia in chronic heart failureInternational Journal of Cardiology, 2002
- Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trialThe Lancet, 2002
- Transfusion Medicine. First of Two Parts. Blood TransfusionJournal of Urology, 1999
- Renal Anaemia Treatment with Recombinant Human Erythropoietin Increases Cardiac Output in Patients with Ischaemic Heart DiseaseScandinavian Journal of Urology and Nephrology, 1996
- Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profilesThe American Journal of Cardiology, 1994
- Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietinAmerican Heart Journal, 1992
- Coagulation Studies and Fistula Blood Flow During Erythropoietin Therapy in Haemodialysis PatientsNephrology Dialysis Transplantation, 1991
- Therapy with Recombinant Human Erythropoietin Reduces Cardiac Size and Improves Heart Function in Chronic Hemodialysis PatientsAmerican Journal of Nephrology, 1991
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987